Moderna announces positive top line data from phase 2/3 study of covid-19 vaccine in children 6 to 11 years of age

Cambridge, mass.--(business wire)--moderna announces positive top line data from phase 2/3 study of covid-19 vaccine in children 6 to 11 years of age
MRNA Ratings Summary
MRNA Quant Ranking